Startup | December 05, 2021
Apollo Health Ventures closes US $ 180 million fund
The fund aims at investing in companies that extends human healthspan
The fund aims at investing in companies that extends human healthspan
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Subscribe To Our Newsletter & Stay Updated
